Medical Devices: FDA Should Enhance Its Oversight of Recalls

Medical Devices: FDA Should Enhance Its Oversight of Recalls

Author: Marcia Crosse

Publisher: DIANE Publishing

Published: 2011

Total Pages: 57

ISBN-13: 1437988067

DOWNLOAD EBOOK

Recalls are an important tool to mitigate serious health consequences associated with defective or unsafe medical devices. Typically, a recall is voluntarily initiated by the firm that manufactured the device. The FDA oversees implementation of the recall. FDA classifies recalls based on health risks of using the recalled device. FDA also determines whether a firm has effectively implemented a recall, and when a recall can be terminated. This report identifies: (1) the numbers and characteristics of medical device recalls and FDA's use of this info. to aid its oversight; and (2) the extent to which the process ensures the effective implementation and termination of the highest-risk recalls. Charts and tables. A print on demand report.


Medical Devices

Medical Devices

Author:

Publisher:

Published: 2011

Total Pages: 51

ISBN-13:

DOWNLOAD EBOOK

Recalls are an important tool to mitigate serious health consequences associated with defective or unsafe medical devices. Typically, a recall is voluntarily initiated by the firm that manufactured the device. The Food and Drug Administration (FDA), an agency within the Department of Health and Human Services (HHS), oversees implementation of the recall. FDA classifies recalls based on health risks of using the recalled device--class I recalls present the highest risk (including death), followed by class II and class III. FDA also determines whether a firm has effectively implemented a recall, and when a recall can be terminated. This report identifies (1) the numbers and characteristics of medical device recalls and FDA's use of this information to aid its oversight, and (2) the extent to which the process ensures the effective implementation and termination of the highest-risk recalls. GAO interviewed FDA officials and examined information on medical device recalls initiated and reported from 2005 through 2009, and reviewed FDA's documentation for a sample of 53 (40 percent) of class I recalls initiated during this period. To aid its oversight of the medical device recall process, FDA should routinely assess information on device recalls, develop enhanced procedures and criteria for assessing the effectiveness of recalls, and document the agency's basis for terminating individual recalls. HHS agreed with GAO's recommendations.


Medical Devices

Medical Devices

Author: United States Government Accountability Office

Publisher: Createspace Independent Publishing Platform

Published: 2018-01-08

Total Pages: 58

ISBN-13: 9781983616839

DOWNLOAD EBOOK

Medical Devices: FDA Should Enhance Its Oversight of Recalls


Medical Devices

Medical Devices

Author: U S Government Accountability Office (G

Publisher: BiblioGov

Published: 2013-06

Total Pages: 40

ISBN-13: 9781289073848

DOWNLOAD EBOOK

The U.S. Government Accountability Office (GAO) is an independent agency that works for Congress. The GAO watches over Congress, and investigates how the federal government spends taxpayers dollars. The Comptroller General of the United States is the leader of the GAO, and is appointed to a 15-year term by the U.S. President. The GAO wants to support Congress, while at the same time doing right by the citizens of the United States. They audit, investigate, perform analyses, issue legal decisions and report anything that the government is doing. This is one of their reports.


Medical Devices and the Public's Health

Medical Devices and the Public's Health

Author: Institute of Medicine

Publisher: National Academies Press

Published: 2011-10-25

Total Pages: 318

ISBN-13: 0309212456

DOWNLOAD EBOOK

Medical devices that are deemed to have a moderate risk to patients generally cannot go on the market until they are cleared through the FDA 510(k) process. In recent years, individuals and organizations have expressed concern that the 510(k) process is neither making safe and effective devices available to patients nor promoting innovation in the medical-device industry. Several high-profile mass-media reports and consumer-protection groups have profiled recognized or potential problems with medical devices cleared through the 510(k) clearance process. The medical-device industry and some patients have asserted that the process has become too burdensome and is delaying or stalling the entry of important new medical devices to the market. At the request of the FDA, the Institute of Medicine (IOM) examined the 510(k) process. Medical Devices and the Public's Health examines the current 510(k) clearance process and whether it optimally protects patients and promotes innovation in support of public health. It also identifies legislative, regulatory, or administrative changes that will achieve the goals of the 510(k) clearance process. Medical Devices and the Public's Health recommends that the U.S. Food and Drug Administration gather the information needed to develop a new regulatory framework to replace the 35-year-old 510(k) clearance process for medical devices. According to the report, the FDA's finite resources are best invested in developing an integrated premarket and postmarket regulatory framework.


Medical Device Recalls

Medical Device Recalls

Author: U S Government Accountability Office (G

Publisher: BiblioGov

Published: 2013-06

Total Pages: 50

ISBN-13: 9781289134747

DOWNLOAD EBOOK

Pursuant to a congressional request, GAO provided information on 1,635 medical devices recalled between fiscal years 1983 and 1988. GAO found that: (1) the Food and Drug Administration (FDA) classified 1,026 of the recalled devices as medium-serious, 561 as least-serious, and 48 as most-serious in terms of potential adverse health consequences; (2) the annual number of recalls fluctuated, with annual totals not exceeding 200 prior to 1985, but consistently near or above 300 after 1985; (3) although recalled devices represented all 19 medical specialty categories, 80 percent of recalled devices fell into 8 categories, and the top 2 categories, cardiovascular and anesthesiology devices, accounted for 25 percent of recalls; (4) even recalls categorized as least-serious could pose serious health consequences; (5) recalled devices included such high-risk, life-supporting devices as replacement heart valves, such medium-risk devices as tanning booths, and such low-risk devices as dental irrigation syringes; (6) design and production problems accounted for almost 75 percent of recalls; (7) 74 percent of all most-serious recalls involved medium-risk devices; (8) only 22 percent of recalls had the required medical device reporting regulation report in their files; (9) about 5 percent of recalled products had received FDA premarketing approval; and (10) premarketing-approved devices were more likely to be classified under the most-serious classification than under the other two categories.


FDA Oversight

FDA Oversight

Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations

Publisher:

Published: 1982

Total Pages: 272

ISBN-13:

DOWNLOAD EBOOK